Beacon Therapeutics
Transforming Vision, Transforming Lives
London, United Kingdom · Founded 2023 · $365.0M raised
- Headquarters
- London
- Employees
- 51–200
- Founded
- 2023
- Business Model
- B2B
- Website
- beacontx.com
- Total Funding
- $365.0M
- Last Round
- $75.0M Series CJan 2026
- Rounds
- 3
About
Beacon Therapeutics is a leading clinical-stage biotechnology company dedicated to saving and restoring sight for people living with rare and prevalent ocular diseases. The company uses adeno-associated virus (AAV) gene therapy to develop treatments for inherited retinal diseases including X-Linked Retinitis Pigmentosa (XLRP), dry Age-related Macular Degeneration (dAMD), and Cone Rod Dystrophy (CRD). Spun out of Syncona and the University of Oxford in 2023, Beacon raised $120M at launch and an additional $170M Series B to advance its lead candidate laru-zova through late-stage clinical trials. The company operates out of London, UK with facilities in Boston, Massachusetts and Alachua, Florida.
Summary
Beacon Therapeutics is a Biotechnology company based in London, United Kingdom, founded in 2023. It has raised $365.0M in total across 3 rounds, most recently a $75.0M Series C round in Jan 2026. Investors include Forbion Capital Partners, Syncona Partners and Oxford Science Enterprises.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Jan 2026
Sign up to see all 3 rounds
Series A through Series C — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
Biotechnology company focused on developing and commercializing innovative, empowered monoclonal ...
Biotechnology company focused on the development of antibody-drug conjugates for the treatment of...
Leading innovative radiopharmaceutical company in China developing next-generation radiopharmaceu...
Clinical-stage biotechnology company pioneering GPCR drug discovery through its proprietary Nativ...
Clinical-stage biopharmaceutical company developing small-molecule therapies for serious diseases...
Specialty therapeutics company focused on gastrointestinal and hepatology diseases and programs
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/beacon-therapeutics"><img src="https://indexed.vc/api/badge/company/beacon-therapeutics" alt="Beacon Therapeutics on Indexed.vc" width="260" height="76" /></a>